ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 2 filers reported holding ONCOCYTE CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $32 | +52.4% | 138,100 | +131.7% | 0.00% | – |
| Q1 2023 | $21 | +133.3% | 59,600 | +111.3% | 0.00% | – |
| Q4 2022 | $9 | -100.0% | 28,200 | -82.1% | 0.00% | – |
| Q1 2022 | $235,000 | -35.4% | 157,450 | -6.2% | 0.00% | – |
| Q4 2021 | $364,000 | +79.3% | 167,900 | +195.1% | 0.00% | – |
| Q3 2021 | $203,000 | -53.2% | 56,900 | -24.7% | 0.00% | -100.0% |
| Q2 2021 | $434,000 | -24.1% | 75,600 | -31.5% | 0.00% | 0.0% |
| Q1 2021 | $572,000 | +300.0% | 110,300 | +47.7% | 0.00% | – |
| Q2 2020 | $143,000 | -73.4% | 74,700 | -45.2% | 0.00% | – |
| Q1 2019 | $538,000 | – | 136,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
| PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
| P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
| Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
| PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
| Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
| Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |